Nav: Home

First cancer patient in Ohio receives proton therapy treatment

July 27, 2016

LITTLETON, Mass., July 26, 2016 - Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals (UH) in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.

The new proton therapy center is located on the main campus of UH, directly between UH Rainbow Babies & Children's Hospital and UH Seidman Cancer Center, part of the elite National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University.

"At UH, we aim to provide the most advanced cancer treatment options, and the addition of our MEVION S250 furthers our commitment to bringing the best cancer care possible to our patients," said Nathan Levitan, MD, president of UH Seidman Cancer Center. "We are particularly excited by the fact that this will be one of the few proton therapy centers in the world to be physically connected to a children's hospital, so both children and adults will be able to benefit from the unmatched precision of proton therapy."

Proton therapy is an advanced form of radiation that targets tumors more directly than traditional radiation, potentially limiting damage to surrounding healthy tissue and organs. This makes proton therapy the ideal treatment for tumors in sensitive areas such as near the eye, brain, spine, heart and lungs. The MEVION S250 at UH will be used for clinical research that will further explore the advantages of proton therapy.

Mevion revolutionized cancer treatment by inventing compact proton therapy and installing the world's first compact proton therapy system in 2013. The MEVION S250 Series provides high-quality treatment and superior clinical performance with a footprint that is less than half the size of the next largest system, capital and operational costs that are the lowest on the market, and industry-leading deployment, ramp-up, beam availability, throughput, and uptime rates.

"Mevion is proud to partner with UH Seidman Cancer Center to open the first proton therapy system in Ohio," said Joseph K. Jachinowski, president and chief executive officer of Mevion Medical Systems. "Our mission is to make proton therapy accessible to all cancer patients, so we're thrilled that patients and their families in Ohio will no longer be forced to leave the state in order to receive this life saving treatment."

The MEVION S250 at UH Seidman Cancer Center is Mevion's fifth clinically operational system and its second at an NCI-Designated Cancer Center. Mevion proton therapy systems are being installed at more NCI-Designated Cancer Centers than any other proton therapy system and Mevion has more compact systems under contract, installed and treating patients than any other company.
-end-


About Mevion Medical Systems


Mevion Medical Systems, Inc. is a leading provider of proton therapy systems for use in radiation treatment for cancer patients. Mevion is privately held and based in Littleton, Massachusetts, with international offices in the United Kingdom and Japan and a joint venture in China. For more information, please visit http://www.mevion.com.

About the MEVION S250 Series


The MEVION S250 Series is elegantly designed to deliver high-powered, efficient proton therapy treatments. Built upon the world's only gantry-mounted proton accelerator and benefitting from Mevion's patented direct beam technology, the MEVION S250 Series delivers on the therapeutic promise of proton therapy while enhancing beam quality, stability and uptime. The result is reduced system complexity, higher reliability and throughput, and lower capital and operating costs--making the MEVION S250 Series a compelling, financially viable solution for all cancer centers. The Series is comprised of:
  • MEVION S250, offering highly stable, next-generation volumetric delivery capabilities
  • MEVION S250i with HYPERSCAN technology, overcoming pencil beam scanning uncertainties by delivering robust Intensity Modulated Proton Therapy treatment at hyper-speed
  • MEVION S250mx, making proton therapy fully scalable, with two, three and four room designs that are inherently redundant and guarantee 100 percent facility uptime


University Hospitals Case Medical Center

Related Proton Therapy Articles:

Proton pump inhibitors do not contribute to dementia or Alzheimer's disease
Noting that the prescription of proton pump inhibitors is on the rise among middle-aged and older adults, a team of researchers designed a new study to examine PPIs and the risk of dementia, mild cognitive impairment, and Alzheimer's disease.
Proton-nuclei smashups yield clues about 'quark gluon plasma'
Findings from Rice University physicists working at Europe's Large Hadron Collider are providing new insight about an exotic state of matter called the 'quark-gluon plasma' that occurs when protons and neutrons melt.
Proton beam power boosted with pulsed lasers, promising better proton therapies
A Japan-based research team led by Osaka University demonstrated multiple sharp, ultra-short laser pulses that promise new types of proton-beam systems potentially useful in areas such as cancer treatment.
Tracking real-time proton induced radiation chemistry in water
Proton therapy is a promising form of radiation treatment used to kill cancerous cells and effectively halt their rapid reproduction, and the fundamental understanding for it is contained in the radiation induced water chemistry that occurs immediately after the interaction.
Advanced form of proton therapy shows promise for treating lung cancer recurrence
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for the treatment of recurrent lung cancer, according to new research from The University of Texas MD Anderson Cancer Center.
Proton therapy offers new treatment possibility for recurrent lung cancer
A new study offers hope for patients with recurrent lung cancer, who historically have been considered ineligible for curative treatment.
Personalized medicine, proton therapy, more advances in lung cancer at upcoming symposium
The press program for next week's 2017 Multidisciplinary Thoracic Cancers Symposium features research advances in lung cancer including immunotherapy, proton therapy and liquid biopsy, among others.
UAB to bring proton therapy for advanced cancer treatment to Birmingham
The University of Alabama at Birmingham will partner with Proton International to bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama.
For the first time, scientists catch water molecules passing the proton baton
Water conducts electricity, but the process by which this familiar fluid passes along positive charges has puzzled scientists for decades.
Proton pump found to regulate blood pH in stingrays
Researchers at Scripps Institution of Oceanography at the University of California San Diego have discovered the same enzyme used by 'boneworms' to dissolve whale carcasses, and that helps promote photosynthesis in corals, also regulates blood pH in stingrays.

Related Proton Therapy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...